AI-generated summary
This review summarizes antifungal drugs in development for onychomycosis, a nail infection, from early phase work through Phase III trials. The authors describe oral azoles, several topical agents, and photosensitizers for photodynamic therapy and new laser systems as emerging options. The abstract reports no pooled efficacy estimates, and the drugs discussed are described as still in development.
- Who or what was studied
- People with onychomycosis (nail plate fungal infection); no specific patient count is reported.
- Limits stated in the abstract
- The abstract is a narrative review that does not report quantitative results or specific trial data.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on tandfonline.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Photodynamic therapy, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.